{"id":"W3171910277","doi":"10.1200/jco.2021.39.15_suppl.tps1101","title":"SERENA-4: A phase 3 comparison of AZD9833 (camizestrant) plus palbociclib, versus anastrozole plus palbociclib, for patients with ER-positive, HER2-negative advanced breast cancer who have not previously received systemic treatment for advanced disease.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Palbociclib; Medicine; Fulvestrant; Anastrozole; Oncology; Internal medicine; Breast cancer; Metastatic breast cancer; Cancer; Aromatase inhibitor; Estrogen receptor; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005605218,0.0005719641,0.004267533,0.0001367053,0.0001436469,0.0000178814,0.0002637179,0.0003401881,0.00005965226],"category_scores_gemma":[0.001611949,0.0004204827,0.001054684,0.0002366659,0.0004705952,0.0003510643,0.000048237,0.000609352,0.000001287199],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002024831,"about_ca_system_score_gemma":0.005861451,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005599745,"about_ca_topic_score_gemma":0.000495232,"domain_scores_codex":[0.9941615,0.0005014726,0.003256836,0.0007146472,0.0006506214,0.0007149423],"domain_scores_gemma":[0.9850186,0.00588015,0.004427408,0.0004661695,0.00335299,0.0008547122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6039305,0.006894081,0.0302978,0.000602596,0.003636068,0.0001594675,0.001234226,0.005634638,0.0005524847,0.00002823015,0.0001591245,0.3468708],"study_design_scores_gemma":[0.6832679,0.1214104,0.1563757,0.006972224,0.006913587,0.0001915541,0.00501563,0.004244287,0.004764929,0.0001394619,0.009721261,0.0009830709],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9822991,0.001700428,0.005247623,0.004023419,0.001255757,0.003460454,0.001923466,0.00003175268,0.0000580178],"genre_scores_gemma":[0.9786606,0.00095309,0.01816633,0.0004834411,0.0007075601,0.0004581253,0.0001611315,0.000108688,0.0003010239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3458878,"threshold_uncertainty_score":0.9998247,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08469489683910919,"score_gpt":0.4701901440886904,"score_spread":0.3854952472495812,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}